Liang‐Ru Ke

Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial

Xing Lv, Xun Cao, Wei‐Xiong Xia et al. · The Lancet Oncology · 2021 · 83 citations

Medicine, Oncology, Pharmacology +15

The diagnostic performance of quantitative mapping in breast cancer patients: a preliminary study using synthetic MRI

Ni He, Haoqiang He, Kui‐Yuan Liu et al. · Cancer Imaging · 2020 · 67 citations · Full text

Medicine, Oncology, Radiology +17

Resveratrol improves glucose uptake in insulin-resistant adipocytes via Sirt1

Sifan Chen, Zhongliang Zhao, Liang‐Ru Ke et al. · The Journal of Nutritional Biochemistry · 2018 · 64 citations

Life Sciences, Biochemistry, Cell Biology +12

Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma

Wang‐Zhong Li, Xing Lv, Dan Hu et al. · JAMA Oncology · 2022 · 60 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer

Wei‐Xiong Xia, Xing Lv, Guoying Liu et al. · Clinical Cancer Research · 2021 · 34 citations · Full text

Medicine, Oncology, Radiation Oncology +13